General Information of the Compound
| Compound ID |
CP0308219
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1H-Indol-2-yl)-piperazin-1-yl-methanone
Show/Hide
|
||||||||||||||||||
| Synonyms |
(1H-Indol-2-yl)-piperazin-1-yl-methanone
(1H-indol-2-yl)(piperazin-1-yl)methanone
136818-95-6
1H-indol-2-yl(piperazin-1-yl)methanone
1H-indol-2-yl-1-piperazinyl-Methanone
2-(piperazin-1-ylcarbonyl)-1H-indole
2-(piperazine-1-carbonyl)-1H-indole
4012AD
AC1LJDZ7
AKOS000210389
ALBB-016237
BDBM50133002
CHEMBL129660
DTXSID30358889
FIVCRRVYLAXYFC-UHFFFAOYSA-N
MCULE-2536499366
MolPort-002-566-226
NS-02944
Oprea1_711133
Piperazine, 1-(1H-indol-2-ylcarbonyl)-
SCHEMBL2679610
STL484224
ZINC509902
piperazoylindole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H15N3O
|
||||||||||||||||||
| Molecular Weight |
229.283
|
||||||||||||||||||
| Canonical SMILES |
O=C(N1CCNCC1)c1cc2ccccc2[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H15N3O/c17-13(16-7-5-14-6-8-16)12-9-10-3-1-2-4-11(10)15-12/h1-4,9,14-15H,5-8H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
FIVCRRVYLAXYFC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound